PDE1-IN-2 is primarily utilized in research focused on understanding the role of phosphodiesterase 1 (PDE1) enzymes in various biological processes. It serves as a selective inhibitor, helping scientists study the enzyme's involvement in cellular signaling pathways, particularly those related to cyclic nucleotides like cAMP and cGMP. This compound is valuable in exploring potential therapeutic applications for conditions where PDE1 activity is implicated, such as cardiovascular diseases, neurological disorders, and certain types of cancer. By modulating PDE1 activity, researchers can investigate its impact on cell proliferation, inflammation, and vascular function, paving the way for the development of targeted treatments. Additionally, PDE1-IN-2 is used in preclinical studies to evaluate its efficacy and safety as a potential drug candidate.